PetIQ, Inc. - Class A (PETQ) earnings
Quarterly and annual PETQ reports and results, each read against the price at its own news timestamp. Back to the PETQ overview →
9 measured PETQ earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PetIQ, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.03% | +0.33% | |
| PetIQ, Inc. Reports Second Quarter 2024 Financial Results | Press release | -0.20% | -0.36% | |
| PetIQ, Inc. to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 | Press release | -0.16% | -2.29% | |
| Form 10-Q PetIQ, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.75% | -2.86% | |
| PetIQ, Inc. Reports First Quarter 2024 Financial Results | Press release | -2.75% | -2.86% | |
| PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 | Press release | +0.00% | +0.73% | |
| Form 10-K PetIQ, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.04% | -5.40% | |
| Form 10-Q PetIQ, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.02% | -11.86% | |
| PetIQ, Inc. Reports Third Quarter 2023 Financial Results | Press release | -4.02% | -11.86% |
Keep exploring
More PETQ: analyst actions → · SEC filings → · PETQ overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Nephros, Inc. (NEPH) | 113 | +1.37% | 58% |
| Compugen Ltd. - Ordinary Shares (CGEN) | 112 | -0.45% | 39% |
| PETLIFE PHARMS INC (PTLF) | 112 | 0.00% | 34% |
| Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO) | 112 | -0.05% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.